Hao Yang1, Xinqi Xiao2, Tonghua Mei3, Ping Zhou4. 1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi No 1 Road, Yuzhong, Chongqing, 400016, People's Republic of China. 2. Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Youyi No 1 Road, Yuzhong, Chongqing, 400016, People's Republic of China. 3. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi No 1 Road, Yuzhong, Chongqing, 400016, People's Republic of China. mtonghua@163.com. 4. Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Youyi No 1 Road, Yuzhong, Chongqing, 400016, People's Republic of China. pingzhou12345@163.com.
Abstract
BACKGROUND: The optimal extent of surgery for older patients with early-stage pulmonary carcinoid tumour (PC) remains controversial. AIMS: To compare prognostic differences between sublobar resection versus lobectomy in older patients with early-stage PC. METHODS: The SEER database was searched for stage T1N0M0 PC patients aged ≥ 65 years who underwent lobectomy or sublobar resection from 2000 to 2017. Propensity score matching (PSM) was used to determine intergroup covariate differences. Kaplan-Meier curves and the log-rank test were used for intergroup comparison of overall survival (OS). A Cox proportional hazard model was used to evaluate independent risk factors. RESULTS: Among 1023 participants, 650 and 373 underwent lobectomy and sublobar resection, respectively. Before PSM, the 5- and 10-year OS in the sublobar resection group were lower than that of the lobectomy group (5-year OS 84.12% vs. 91.16%; 10-year OS 57.43% vs. 64.77%; p = 0.014); after PSM, no significant prognostic difference existed between lobectomy and sublobar resection (5-year OS 88.17% vs. 89.23%; 10-year OS 58.32% vs. 62.75%; p = 0.811). Subgroup analysis included tumour size, age, number of lymph nodes examined and histological type, and showed no statistically significant survival differences between the lobectomy and sublobar resection groups. Multivariable Cox analysis indicated that age ≥ 77 years, male sex, inadequate lymph node assessment (< 7), and atypical carcinoid were associated with reduced OS. CONCLUSION: Sublobar resection showed a similar long-term survival rate for early-stage PC patients aged ≥ 65 years as with lobectomy, thereby providing a basis for the selection of surgical methods for PC.
BACKGROUND: The optimal extent of surgery for older patients with early-stage pulmonary carcinoid tumour (PC) remains controversial. AIMS: To compare prognostic differences between sublobar resection versus lobectomy in older patients with early-stage PC. METHODS: The SEER database was searched for stage T1N0M0 PC patients aged ≥ 65 years who underwent lobectomy or sublobar resection from 2000 to 2017. Propensity score matching (PSM) was used to determine intergroup covariate differences. Kaplan-Meier curves and the log-rank test were used for intergroup comparison of overall survival (OS). A Cox proportional hazard model was used to evaluate independent risk factors. RESULTS: Among 1023 participants, 650 and 373 underwent lobectomy and sublobar resection, respectively. Before PSM, the 5- and 10-year OS in the sublobar resection group were lower than that of the lobectomy group (5-year OS 84.12% vs. 91.16%; 10-year OS 57.43% vs. 64.77%; p = 0.014); after PSM, no significant prognostic difference existed between lobectomy and sublobar resection (5-year OS 88.17% vs. 89.23%; 10-year OS 58.32% vs. 62.75%; p = 0.811). Subgroup analysis included tumour size, age, number of lymph nodes examined and histological type, and showed no statistically significant survival differences between the lobectomy and sublobar resection groups. Multivariable Cox analysis indicated that age ≥ 77 years, male sex, inadequate lymph node assessment (< 7), and atypical carcinoid were associated with reduced OS. CONCLUSION: Sublobar resection showed a similar long-term survival rate for early-stage PC patients aged ≥ 65 years as with lobectomy, thereby providing a basis for the selection of surgical methods for PC.
Authors: E Baudin; M Caplin; R Garcia-Carbonero; N Fazio; P Ferolla; P L Filosso; A Frilling; W W de Herder; D Hörsch; U Knigge; C M Korse; E Lim; C Lombard-Bohas; M Pavel; J Y Scoazec; A Sundin; A Berruti Journal: Ann Oncol Date: 2021-01-19 Impact factor: 32.976
Authors: Daniel P Nussbaum; Paul J Speicher; Brian C Gulack; Matthew G Hartwig; Mark W Onaitis; Thomas A D'Amico; Mark F Berry Journal: Ann Thorac Surg Date: 2014-12-10 Impact factor: 4.330
Authors: James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans Journal: J Clin Oncol Date: 2008-06-20 Impact factor: 44.544
Authors: Peter J Kneuertz; Mohamed K Kamel; Brendon M Stiles; Benjamin E Lee; Mohamed Rahouma; Sebron W Harrison; Nasser K Altorki; Jeffrey L Port Journal: Ann Thorac Surg Date: 2018-06-15 Impact factor: 4.330
Authors: Muhammad Furqan; Yu-Yu Tien; Mary C Schroeder; Kalpaj R Parekh; John Keech; Bryan G Allen; Alexandra Thomas; Jun Zhang; Gerald Clamon; Taher Abu Hejleh Journal: J Thorac Dis Date: 2018-10 Impact factor: 2.895
Authors: Natalie Prinzi; Roberta Elisa Rossi; Claudia Proto; Giovanni Leuzzi; Alessandra Raimondi; Martina Torchio; Massimo Milione; Francesca Corti; Elena Colombo; Michele Prisciandaro; Tommaso Cascella; Carlo Spreafico; Teresa Beninato; Jorgelina Coppa; Giuseppe Lo Russo; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu Journal: Clin Lung Cancer Date: 2020-12-17 Impact factor: 4.785